Form 4: Dolby CEO Transfers Stock Options to Trust

Dolby Laboratories CEO Kevin Yeaman transferred 145,252 employee stock options to a revocable trust for estate planning purposes.

Summary

• Kevin J. Yeaman, President and CEO, and a Director of Dolby Laboratories, Inc. (DLB), reported a transaction on February 5, 2026.
• Yeaman transferred an employee stock option for 145,252 shares to a revocable trust for estate planning purposes, receiving no consideration.
• The transferred options have an exercise price of $66.62 and an expiration date of December 15, 2035.
• Vesting for these options begins on December 15, 2025, with 1/4 vesting on the first anniversary and the remainder vesting in equal monthly installments over the subsequent 36 months.
• This transfer is exempt from Section 16(b) under Rule 16b-5.
• Following the reported transaction, Yeaman beneficially owns 145,252 derivative securities directly and 145,252 derivative securities indirectly through the Kevin and Rachel Yeaman Family Trust dated May 14, 2009.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It is a routine personal financial transaction by an executive and does not reflect positively or negatively on the company's operational performance or future outlook.

Positives

• The transfer is for estate planning purposes, indicating proactive personal financial management by the CEO.
• The transaction is exempt from Section 16(b), suggesting compliance with SEC rules for insider transactions.

Future Outlook

The filing does not contain forward-looking statements or guidance related to the company's future performance or strategic direction. It pertains to a personal transaction of an executive.

Management Comments

• "Effective February 5, 2026, the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes."
• "This transfer is exempt from Section 16(b) by virtue of Rule 16b-5."

Industry Context

StockSavvy.ai notes that insider transfers of equity to family trusts for estate planning are common and generally do not reflect a change in management's confidence in the company's prospects. Such transactions are typically personal financial management decisions rather than signals about the company's operational or financial health.

Comparison to Industry Standards

• This type of insider transaction, involving the transfer of stock options to a revocable trust for estate planning, is a standard practice among executives in publicly traded companies across various industries.
• It aligns with common personal wealth management strategies and does not indicate any deviation from typical corporate governance or financial practices observed in companies like Apple, Microsoft, or Google, where executives frequently manage their equity holdings through similar structures.

Stakeholder Impact

• Shareholders: No direct impact on company operations or share value. The CEO retains beneficial ownership, maintaining alignment of interests.
• Employees, Customers, Suppliers, Creditors: No discernible impact.

Next Steps

• The options will vest according to the schedule: 1/4 on December 15, 2026, and the remainder in equal monthly installments over the subsequent 36 months.
• The options can be exercised at $66.62 per share until December 15, 2035.

Key Dates

Recommendation

This Form 4 filing reports a routine personal financial transaction by the CEO, transferring stock options to a revocable trust for estate planning. It does not provide any new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions based on existing company fundamentals and market conditions.

Keywords

Dolby Laboratories, DLB, Kevin Yeaman, Form 4, Insider Transaction, Stock Option Transfer, Estate Planning, CEO, Director, Beneficial Ownership